Jonathon R. Campbell

3 ta ish

McGill University

1. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

   Sharh maqolaOAOchiq kirish20204 iqtibos

   ABIABI:AkademIndex/2026.other.006851

2. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

   ABIABI:AkademIndex/2019.article.000020

3. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

   Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

   Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos

   ABIABI:AkademIndex/2025.review-article.000036